Oxbridge Re Reports Q4 2023 Financial Results with Positive Outlook

Written by Emily J. Thompson, Senior Investment Analyst

Source: seekingalpha

Updated: Mar 30 2026

0mins

OXBR+2.88%

Should l Buy OXBR?

Source: seekingalpha

Financial Highlights: Oxbridge Re reported a GAAP EPS of $0.02 for Q4 2023, with revenue of $0.58M reflecting a 38.1% year-over-year increase, indicating strong growth momentum that boosts investor confidence.
Contract Cycle Preparation: The company is gearing up for the 2026-2027 contract cycle with two tokenized reinsurance offerings, T20 and T42, targeting annual returns of 20% and 42%, respectively, which will provide new avenues for revenue growth.
Industry Outlook: Industry commentary, including reports from Artemis referencing AccuWeather forecasts, suggests that the 2026 Atlantic hurricane season may be positively influenced by El Niño conditions, historically associated with reduced storm activity, potentially benefiting the reinsurance market.
Market Response: With improved financial performance and the launch of future products, Oxbridge Re is positioned to gain a competitive edge in the reinsurance market, enhancing its market share and brand influence.

Trade with 70% Backtested Accuracy

Stop guessing "Should I Buy OXBR?" and start using high-conviction signals backed by rigorous historical data.

Analyst Views on OXBR

About OXBR

Oxbridge Re Holdings Limited is a Cayman Islands-based specialty property and casualty reinsurer. The Company offers tokenized Real-World Assets (RWAs) as tokenized reinsurance securities and reinsurance business solutions to property and casualty insurers, through its subsidiaries Oxbridge Re NS and Oxbridge Reinsurance Limited. The Company operates through the Property and Casualty Reinsurance segment. It focuses on underwriting fully collateralized reinsurance contracts for property and casualty insurance in the Gulf Coast region of the United States. The Company’s subsidiary, Oxbridge Re NS functions as a reinsurance sidecar which increases the underwriting capacity of Oxbridge Reinsurance Limited. Oxbridge Re NS issues participating notes to third party investors, the proceeds of which are utilized to collateralize Oxbridge Reinsurance Limited’s reinsurance obligations.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

Oxbridge Re Holdings Reports Q4 2025 Earnings Highlights

Mar 30 2026seekingalpha

Financial Performance Review: In Q4 2025, net premiums earned were $555,000, down from $595,000 in Q4 2024, reflecting lower average rates on reinsurance contracts, although total revenue increased from $422,000 to $576,000, indicating efforts in revenue diversification.
Net Income Improvement: The net income for Q4 2025 was $120,000, or $0.02 per share, compared to a net loss of $460,000 or $0.05 per share in Q4 2024, demonstrating significant progress in profitability despite higher expenses and adverse loss development.
Strategic Expansion Plans: Management announced plans to target returns of 20% and 42% for its T20 and T42 tokenized reinsurance offerings in the 2026-2027 contract cycle, reflecting confidence in future growth opportunities, particularly in the tokenization of AI-related revenue streams.
Strong Liquidity Position: Cash and restricted cash totaled approximately $7 million at year-end, up from $5.89 million, with management indicating this positions the company well for evaluating reinsurance tokenization and other opportunities, enhancing future investment capabilities.